Full-Time

Senior Tech Vendor Relations Analyst

Syneos Health

Syneos Health

10,001+ employees

Global provider of integrated clinical-to-commercial services

No salary listed

Hyderabad, Telangana, India

Hybrid

Hybrid role based in Hyderabad; some on-site days required.

Bachelor's

Category
Operations & Logistics (1)
Required Skills
Computer Networking
Visio
Excel/Numbers/Sheets
PowerPoint/Keynote/Slides

Get referred to Syneos Health

See people who can refer or advise you

Requirements
  • Bachelor’s degree in IT, business or equivalent experience
  • Two-years or equivalent customer service experience
  • Carries out all responsibilities in an honest, ethical and professional manner
  • Excellent communication (written and oral) and interpersonal skills
  • Ability to interact effectively at all levels and across diverse cultures
  • Ability to adapt as the external environment and organization evolves
  • Proven performance demonstrating flexibility, ability to prioritize, and work analytically in a problem-solving environment
  • Ability to conduct research on industry best practices and effectively apply to situation
  • Demonstrated familiarity with Accounts Payable procedures, invoice processing, and auditing
  • Solid understanding of telecommunications and networking concepts, principles, and knowledge of systems connectivity to understand overall flow of leased services
  • Prior experience with the IT project initiation process and gathering business requirements
  • Ability to manage projects with strong cross-functional collaboration skills
  • Excellent PC skills, including Excel, PowerPoint, process-mapping software (Visio)
  • Deep understanding of the full lifecycle of contracts
  • Strong understanding of legal terms and conditions and demonstrated negotiation skills coupled with extensive knowledge of business and contract law related to Technology services
  • Prior experience with reviewing/ modifying legal contracts and documents (MSAs, SOWs, NDAs, etc.)
  • Experience with corporate managed devices and Mobile Device Management Platforms (such as Asignet, Cass Information Systems, Sakon, Rivermine, Tangoe, etc.)
  • Knowledge of pricing and benchmarking of telecom services
  • Forensic analysis of telecom invoices (receiving, reviewing, approving, auditing, optimizing, processing, validating payment, etc.)
  • Track telecom usage and trends to forecast future expenses and plan accordingly
  • Identify coding discrepancies to ensure accurate cost center and GL allocations
  • Coordinate with fixed line vendors to provide periodic utilization stats for review by Tech partners
  • Support green initiatives with responsible mobile recycle plan
Responsibilities
  • Serves as the Vendor Relationship Owner (VRO) for assigned vendors
  • Maintains strong relationships with vendors
  • Evaluates vendor performance, conducts vendor risk assessments and scheduled vendor reviews
  • Manages all related vendor contracts and facilitates contract negotiation
  • Manage and analyze telecom expenses to identify cost-saving opportunities
  • Managing the acquisition of mobile devices and services
  • Coordination with telecom vendors to negotiate contracts and resolve billing discrepancies
  • Knowledge of and understanding of pricing and benchmarking of telecom services
  • Forensic analysis of telecom invoices including receiving, reviewing, approving, auditing, optimizing, processing, validating payment, etc.
  • Develop and implement strategies to optimize telecom expenses while maintaining service quality
  • Supports monthly allocation process ensuring technology costs are billed to the appropriate business unit
  • Track telecom usage and trends to forecast future expenses and plan accordingly
  • Identify coding discrepancies to ensure accurate cost center and GL allocations
  • Experience working with corporate managed devices and Mobile Device Management Platforms
  • Coordinate with fixed line vendors to provide periodic utilization stats for review by Tech partners
  • Support green initiatives with responsible mobile recycle plan
Desired Qualifications
  • Professional TEM certification preferred

Syneos Health provides end-to-end biopharmaceutical solutions across the clinical-to-commercial spectrum. It helps biopharma companies, healthcare organizations, and investors by offering specialized expertise, insights, and technology-enabled services to move therapies faster to patients. Its offerings include Kinetic, a modern omnichannel customer engagement platform that uses targeting and analytics to coordinate nationwide healthcare communications, and Syneos One, an asset development approach that aligns strategy and execution from early concept through commercialization. The company uses AI and advanced tech to improve performance and reduce risk in drug development and market delivery. Its goal is to be a trusted partner that accelerates therapy development and delivery by combining scientific know-how with integrated, data-driven services.

Company Size

10,001+

Company Stage

IPO

Headquarters

Morrisville, North Carolina

Founded

1985

Get referred to Syneos Health

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Helio Genomics chose Syneos on May 19 2026 to commercialize HelioLiver nationwide.
  • Syneos embedded KAI Conversations on April 30 2026 for AI-driven U.S. commercialization.
  • May 14 2026 partnerships with CausaLens and Sageforce expand AI commercial tooling rapidly.

What critics are saying

  • Kempen v. Syneos entered discovery after the March 31 2026 dismissal ruling.
  • Plaintiffs allege Syneos inflated backlog and book-to-bill from 2020 through 2022.
  • Private-equity owners can prioritize leverage and cost cuts over R&D reinvestment by 2027.

What makes Syneos Health unique

  • Syneos spans preclinical through commercialization with a 2026 lab-to-life service model.
  • Kinetic unifies proprietary and partner intelligence for field execution and commercial precision.
  • Greg Licholai’s June 1 2026 CMO appointment deepens drug-development credibility with biopharma clients.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Company Match

Employee Stock Purchase Plan

Flexible Work Hours

Paid Vacation

Paid Sick Leave

Remote Work Options

Company News

PR Newswire
May 19th, 2026
Helio Genomics partners with Syneos Health to accelerate adoption of AI-powered liver cancer blood test

Helio Genomics has partnered with Syneos Health to accelerate nationwide adoption of HelioLiver, an AI-powered blood test for early liver cancer detection. Syneos Health will deploy field engagement and educational initiatives to reach hepatologists and gastroenterologists managing high-risk populations across the United States. HelioLiver combines cell-free DNA methylation patterns, protein biomarkers and patient demographics using proprietary AI algorithms. In the CLiMB trial involving nearly 1,968 patients across 50 clinical sites, the test demonstrated four times greater sensitivity for Stage I liver cancer compared to ultrasound. The test is reimbursed by Medicare at $662. The partnership builds on Helio Genomics' recent collaboration with Quest Diagnostics, providing access to over 7,700 patient service centres nationwide. Liver cancer incidence rates have tripled in the US since 1980.

Wallowa.com
Apr 30th, 2026
KAI Conversations announces strategic partnership with Syneos Health to advance U.S. Pharmaceutical commercialization.

KAI Conversations announces strategic partnership with Syneos Health to advance U.S. Pharmaceutical commercialization. GlobeNewswire | Syneos Health, Inc. Today at 9:30am PDT LONDON, April 30, 2026 (GLOBE NEWSWIRE) - KAI Conversations, an AI-powered conversation intelligence platform purpose-built for the pharmaceutical industry, today announced a strategic partnership with Syneos Health(R), a leading fully integrated biopharmaceutical solutions organization, to bring AI-driven field insights to the U.S. biopharma market. Pharmaceutical companies invest an estimated 30-50% of revenue in field teams, yet the majority of HCP interactions fail to translate into meaningful impact. This collaboration is designed to address that gap by helping companies turn everyday field conversations into actionable insights, more effective engagement and stronger brand performance. Through this strategic partnership, Syneos Health will embed KAI's platform into its commercial solutions - among the broadest in the industry - further strengthening the Company's ability to optimize field execution, accelerate behavior change and translate data-driven signals into measurable performance gains. KAI's platform, used by 10 of the top 20 global pharmaceutical companies across 15 therapeutic areas and multiple continents, analyzes conversations between field teams and healthcare professionals (HCPs). The platform delivers coaching to individual sales representatives while generating aggregated brand and customer intelligence for commercial and medical leaders. "The U.S. market represents a critical opportunity for pharmaceutical innovation and commercialization," said David Williams, Founder and CEO of KAI Conversations. "Partnering with Syneos Health enables us to scale our conversation intelligence through a trusted commercialization leader - equipping field teams with contextual coaching and insights to drive HCP engagement and stronger brand outcomes." "For years, valuable field insights were effectively invisible, locked inside everyday HCP conversations," said Paul Mignon, Head of Deployment Solutions at Syneos Health. "With KAI, we're surfacing real-time signals so our expert teams can optimize what works, predict what matters and automate next-best actions - driving precision performance to accelerate launch, adoption and growth." Together KAI and Syneos Health are advancing pharmaceutical commercialization by aligning AI-powered insights with integrated strategy, commercial execution and performance optimization. About KAI Conversations KAI Conversations is the world's leading AI conversation intelligence platform purpose-built for the pharmaceutical industry. The platform reveals previously hidden human insights by analyzing conversations between pharmaceutical field teams and healthcare professionals. By providing actionable insights and coaching, KAI empowers individuals and central teams to drive more effective engagement, enhance commercial outcomes, and accelerate brand performance. For more information, visit kaiconversations.com. This is a paid placement. For further inquiries, please contact GlobeNewswire directly.

Fierce Biotech
Mar 19th, 2026
Syneos Health scoops up Chinese CRO to secure place in ‘rapidly growing market’

North Carolina-based contract research organization Syneos Health is making a play to capitalize on China’s rapidly ascendant biopharma industry. | North Carolina-based contract research organization Syneos Health is making a play to capitalize on China’s rapidly ascendant biopharma industry. Syneos has acquired Chinese CRO Bestudy to secure a foothold in the Asian nation.

PRWeek
May 7th, 2025
Imre hires Greg Voyles as chief growth officer

Voyles joins Imre from Syneos Health, where he served as VP of commercial solutions.

Healthcare Asia Magazine
Dec 2nd, 2024
Sunway Healthcare Group, Syneos Health to expand clinical trial expertise

Sunway Healthcare Group has partnered with Syneos Health to expand clinical trial capabilities across therapeutic areas in Malaysia.